However, when comparing the DKK3 mRNA expression levels between grade II or III glioma and GBM, we found that DKK3 expression was significantly decreased in GBM compared with grade II or III glioma (Fig. 1C). This evidence concerns the gene DKK3 and central nervous system cancer.